This, combined with the observed IC deposition within the joints of RA patients [355], suggests that impaired FcγRIIB-mediated IC removal may contribute to the pathogenesis of RA, and potentially other autoimmune diseases. The gene discussed is FCGR2B; the disease is rheumatoid arthritis.